Skip to main content
Iranian Endodontic Journal logoLink to Iranian Endodontic Journal
. 2022 Winter;17(1):1–6. doi: 10.22037/iej.v17i1.27165

Comparison of Gene Expression of Different Isoforms of Osteopontin in Symptomatic Irreversible Pulpitis of Human Dental Pulp

Farnaz Salehi a,b, Masoomeh Dibaj b, Aram Mohammadi c, Mandana Sattari a,c,*
PMCID: PMC9868985  PMID: 36703874

Abstract

Introduction:

Osteopontin (OPN), plays an important role in immune system modulation. OPN can activate osteoclasts, thus causing resorption of bone. In addition, it might have a protective function against polymicrobial endodontic infections. Since different isoforms of OPN might have diverse roles, the aim of the present study was to compare gene expression of different isoforms of osteopontin in symptomatic irreversible pulpitis and normal pulps of the human dental pulp.

Materials and Methods:

Pulps were taken from 20 teeth with symptomatic irreversible pulpitis as the case group and from 20 intact premolars scheduled for extraction as the control group. After RNA extraction and synthesis of complementary DNA (cDNA), quantitative real-time polymerase chain reaction (PCR) was used for the evaluation of gene expression of OPN, OPN2 and OPN3. The Mann-Whitney U, t and Chi-square tests were used to analyze differences between the groups.

Results:

Mean values of OPN, OPN2 and OPN3 in normal pulps were 0.695±0.295, 0.656±0.298 and 0.816±0.422, respectively. Mean values of OPN, OPN2 and OPN3 in symptomatic irreversible pulpitis were 2.52±1.82, 1.99±0.899 and 1.816±0.954, respectively. Unlike OPN and OPN2, OPN3 exhibited significantly higher expression in normal pulps (P<0.05).

Conclusion:

The results of the present case- control study showed that some variants of OPN are upregulated during pulpitis and it might be due to their prominent modulatory roles in dental pulps.

Key Words: Human Dental Pulp, Irreversible Pulpitis, Osteopontin

Introduction

Pulpitis is a condition of the pulp connective tissue, which is induced by microorganisms involved in the caries process, tooth restorative procedures and trauma. There are two distinctive stages in pulpitis, requiring different treatment plans: reversible pulpitis in which the pulp is preserved and irreversible pulpitis in which in most cases, it is not possible to preserve the pulp vitality [1, 2]. Irreversible pulpitis might be symptomatic or asymptomatic, with the symptomatic form being more common and the majority of patients seek treatment only due to pain [3, 4]. In this condition, the pulp loses its reparative capacity and finally undergoes necrosis due to lack of treatment. The treatment consists of pulpectomy and root canal therapy. The pulp disease triggers the host’s defensive reactions, the principal aim of which is to limit the inflammation [5]. During these defensive reactions, inflammatory mediators are synthesized, which have the capacity to cause soft and hard tissue destruction [1, 3].

Osteopontin (OPN) is encoded by the secreted phosphoprotein 1 gene. OPN, in the bone marrow, makes up about 2% of non-collagen bone and is predominantly secreted by osteoblasts. It was originally identified as a bone matrix protein but later it became clear that OPN is also a cytokine and is synthesized by different cells, including fibroblasts, preosteoblasts, osteoblasts, osteocytes, odontoblasts, dendritic cells, macrophages, endothelial cells and T cells [6-10]. When these cells are exposed to proinflammatory cytokines, osteopontin is synthesized. Classic acute inflammatory mediators such as tumor necrosis factor-alpha (TNF-α) and interleukin-1beta (IL-1β) can result in the expression of this protein [8, 11, 12]. It has recently been shown that osteopontin can play a protective role against polymicrobial endodontic infections. It was also shown that in response to some kind of inflammatory stimuli, there is an increase in OPN in order to participate in tissue repair [13]. In addition, an increase has been shown in osteopontin concentration in reparative dentin and its passive inductive role in the initiation of the pulp regenerative process [14]. On the other hand, the role of osteopontin has been shown in stimulation and activation of osteoclasts [15-17]. It has also been reported that OPN correlates with tumorigenesis, progression and metastasis of different malignancies in experimental and clinical models [18]. OPN also is involved in biological activities such as proliferation, adhesion, and migration of several bone-related cells, such as osteoclasts, osteoblasts and bone marrow mesenchymal stem cells [19]. So, OPN is a multifunctional soluble molecule in extracellular matrix (ECM) [20, 21]. Given the presence of 5 isoforms of osteopontin [22], the differences in the results might be attributed to differences in osteopontin isoforms. It should be pointed out that due to the small size of messenger RNA (mRNA) of isoforms 1 and 4 and 100% similarity to isoform 5, in the pilot study many cross-reactions were observed between primers 1, 4 and 5. In particular, isoform 5 participated in primer dimer reactions, resulting in unreliable responses [22]. Therefore, these three primers were excluded from the study. Since the role of this phosphorylated protein and the expression rates of its different isoforms have not been elucidated in pulpitis and most studies in this field have focused on the reparative effects of osteopontin, the present study was undertaken to compare the expression of its different isoforms (isoforms 2 and 3) in symptomatic irreversible pulpitis and in healthy control teeth, in order to find precise role of OPN in dental pulp health or in pulpitis and determine whether specific isoforms are involved or not. As we know in order to adopt the best treatment strategy, it is necessary to know the mechanism of pathogenesis and the molecules involved in it.

Materials and Methods

Subject selection

This study was ethically conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from all of patients. The protocol was approved by Dental Research Center and Ethics Committee of Medical School of Shahid Beheshti University of Medical Sciences (The code of Ethics: IR.SBMU.MSP.REC.1394.121).

The subjects were selected from 14‒25-year-old patients referring to the Department of Endodontics, Faculty of Dentistry, Islamic Azad University, Tehran Branch. The sampling method was non-probable and the samples were collected from the available population, based on the prevalence of the disease and Cochran formula (Cochran) [23].

Twenty subjects with symptomatic irreversible pulpitis were selected, with the following symptoms and signs: sustained sensitivity to cold, spontaneous pain, normal or increased response to percussion and absence of any evidence of periapical pathosis on the radiograph of posterior teeth. The subjects had moderate to severe pain for at least 24 h prior to selection and had not taken any analgesics.

After administration of anesthesia the tooth in question was isolated with rubber dam, access cavity was prepared after excavation of caries and the coronal pulpal tissue was removed with a sterile excavator [24].

Twenty normal pulps with a positive response to vitality tests (cold test), without spontaneous pain on percussion or mastication, caries or any symptoms and signs of pathosis in the periapical area on periapical radiographs, were selected in patients referring for extraction of their premolar teeth for orthodontic treatment. After local anesthesia and extraction of teeth, a cylindrical diamond bur was used in a high-speed handpiece to create a vertical cut along the long axis of the tooth without impinging on the root canal. Then a chisel was used to divide the tooth into two halves and the coronal pulpal tissue was gently removed with the use of a spoon excavator [24].

A scalpel blade was used to divide the pulpal samples into small pieces within a Petri dish and transferred into cryotubes containing RNA Later (Catalog number: AM7020; Thermo Fisher Scientific, Cleveland, OH, USA). After 24 h and penetration of the solution into the pulpal tissue, the samples were transferred into a freezer for long-term storage at -20°C [25].

Gene expression analysis

Homogenization of the tissue samples

The pulpal tissue samples were retrieved from the RNA Later solution and homogenized with TissueLyser II (Catalog number: 85300; Qiagen, Hilden, Germany) equipment and prepared for RNA purification.

RNA extraction and cDNA synthesis

After homogenizing the pulpal tissue, RNA was extracted by RNA isolation kit (in the presence of Lysis/Binding buffer, DNase, washing buffer I,II, and Elution buffer) according to the manufacturer’s protocol (High pure RNA Isolation kit, Catalog number: 11828665001; LifeScience, Roche, Mannheim, Germany). The quality of the total RNA was confirmed by the %2 agarose gel electrophoresis, followed by visualization of the bands using ultra violet (UV) transilluminator and Gel Doc and observation 3 bands, 5S, 18S, and 28S RNA. Its concentration and purity were evaluated by measuring the absorbance at 260 nm and the 260/280 nm ratio, respectively, using spectrophotometer, and the Optical density (OD) ratio was >1.8 [26].

Complementary DNA was synthesized, by reverse transcription .01-5µg of total RNA in the presence of Reaction buffer, Oligo (dT), Revert Aid™ MMLV (Moloney Murine Leukemia Virus) Reverse Transcriptase, MgCl2, dNTPs, RiboLock™ RNase Inhibitor, according to the manufacturer’s protocol (Reverted First Strand cDNA Synthesis Kit, Catalog number: 00146314; Thermo Scientific Fermentas, Vilnius, Lithuania).

Designing primer

The sequence of the genes were taken from the website at http://www.ncbi.nlm.nih.gov and Beacon Designer software was used to design reverse and forward primers (Table 1).

Table 1.

Designed primers for OPNs and RPOL2

Gene Sequence
Osteopontin (OPN)
Forward AATGATGAGAGCAATGAG
Reverse GTCTACAACCAGCATATC
Variant 2 or b of OPN
Forward ATCTCCTAGCCCCACAGACCC
Reverse AAACTTCGGTTGCTGGCAGG
Variant 3 or c of OPN
Forward AGGCATCACCTGTGCCATAC
Reverse GAGGACACAGCATTCTGCTTTT
RNA Polymerase II (RPOL2)
Forward TAACGCCTGCCTCTTCACGTTGA
Reverse ATGAGGGACCTTGTAGCCAGCAA

It should be pointed out that since mRNA of isoforms 1 and 4 was small and due to its 100% similarity with isoform 5, in the pilot study many cross-reactions were observed between primers 1, 4 and 5; in particular, isoform 5 participated in primer dimer reactions, resulting in unreliable responses. Therefore, these three primers were excluded from the study. In order to make it possible to compare the results of the present study with those of other studies in which only the expression of OPN has been evaluated, its primer was used in the present study.

Quantitative real-time PCR (qRT-PCR)

To determine the ideal concentration of primers, different concentrations (0.5, 0.8, 1 and 1.5 μM) were tested and 0.5 mM for each primer was selected as the best.

SYBR Green I real time PCR assay was carried out in final reaction volume of 25 μL with 12.5 μL of SYBR Green I Master mix (SYBR® Premix Ex Taq????

Calculations to determine the relative level of gene expression were made by reference to the RPOL2 in each sample, using cycle threshold method. The data were analyzed by the system software11. Cycle threshold (Ct) value of reference or housekeeping gene RNA Polymerase II (RPOL2) was subtracted from Ct value of the target gene (IL-22) to obtain ΔCt (Delta ycle threshold). After that ΔΔCt was calculated (ΔCt target0-ΔCt reference).The calculated ΔΔCt was converted to Ratio using the Ratio formula (Ratio=2-ΔΔCt).

Statistical analysis

All data were analyzed using SPSS 21.0 statistic software program (IBM Corporation, Armonk, NY, USA). Due to the lack of normal distribution of the main data, which was shown by Kolmogorov-Smirnov test, non-parametric test including Mann Whitney U test has been used. P<0.05 was considered statistically significant.

Results

The mean ages in the healthy pulp and pulpitis group subjects were 16.95±3.62 and 25.70±4.24 years, respectively, indicating that the two groups were not matched (t-test) in relation to their age because healthy samples were collected from subjects who needed orthodontic treatment (P<0.03). In relation to gender, the healthy group consisted of 15 females and 5 males and the pulpitis group consisted of 13 females and 7 males. The Chi-squared test did not show any significant difference in gender between the two groups (P>0.3).

Kolmogorov-Smirnov test showed that the distribution of the expression of OPN, OPN2 and OPN3 were not normal (P<0.05). Therefore, non-parametric tests were used for the analyses of the above mentioned variables.

In Tables 2 and 3 the expression of OPN, OPN2 and OPN3, respectively, was compared between healthy and symptomatic pulpitis groups by the Mann-Whitney U test.

Table 2.

Descriptive statistics for OPN, OPN2 and OPN3 gene expression (ΔΔCt) in healthy and symptomatic pulpitis groups

Variables
Parameters
Normal Pulp Symptomatic Pulpitis
OPN OPN2 OPN3 OPN OPN2 OPN3
Number 20 20 1.05 20 20 20
Minimum 0.24 0.17 0.20 0.54 0.78 0.90
Maximum 1.05 1.04 1.78 2.52 1.99 1.81
Mean(SD) 0.69 (0.29) 0.65 (0.29) 0.81 (0.42) 2.52 (1.82) 1.99 (0.89) 1.81 (0.95)

Table 3.

Comparison of expression of OPN, OPN2 and OPN3 genes between healthy and symptomatic pulpitis groups by Mann Whitney U test

OPN
Group Mean rank Total rank Mann-Whitney U P -value
Healthy 13.30 266.00 56.000 <0.001
Pulpitis 27.70 554.00
OPN2
Group Mean rank Total rank Mann-Whitney U P -value
Healthy 11.20 224.00 14.000 <0.001
Pulpitis 29.80 596.00
OPN3
Group Mean rank Total rank Mann-Whitney U P -value
Healthy 12.50 250.00 40.000 <0.001
Pulpitis 28.50 570.00

Based on the data presented in Table 3, there was a significant difference in the expression of OPN, OPN2, OPN3 between the healthy subjects and subjects with pulpitis (P<0.001). So that there is higher expression of OPN, OPN2, OPN3 in pulpitis.

By comparing different OPNs in healthy pulps, we found higher expression of OPN3 in healthy pulps than the two other OPNs (P<0.01) but we could not find any significant difference regarding OPNs expression in symptomatic pulpitis group.

Figure 1 compares the expression of OPN, OPN2 and OPN3 between the healthy and pulpitis groups.

Figure 1.

Figure 1

Electrophoresis of real-time PCR products on 2% agarose gel. In relation to OPN total, OPN variant 2, OPN variant 3 and RPOL2 genes, the products have undergone electrophoresis along with a 50-bp marker. The name of each band, along with its size, has been written under the band

Discussion

Based on the available references, the present study is the first study that evaluate the expression of OPN and its isoforms in human teeth with symptomatic irreversible pulpitis.

The results of the present study showed significant differences in the expression of OPN, OPN2 and OPN3 between healthy pulps and pulps with symptomatic irreversible pulpitis, so that the expressions of OPN, OPN2 and OPN3 in pulpitis were 3.6, 3.04 and 2.34 times more than healthy pulp.

As pointed out previously, osteopontin is the glycoprotein first discovered in osteoblasts but it was later shown that it could be expressed in other tissues, too [6-8] including the dental pulp [27]. A study by Kaneko et al. [28] showed a higher expression rate of osteopontin in the apical pulp compared to the coronal pulp, with the highest expression rate of OPN in the periodontal ligament of healthy teeth of rats.

Consistent with the results of previous studies, indicating that inflammatory mediators result in the expression of this protein [8, 11, 12]. Our study was done on the coronal pulp which has considerably higher number of immune cells than apical pulp [29]; thus, it would be a better region of pulp in order to find inflammatory mediators which are produced by immune cells. In addition, we used Real-time PCR in order to measure gene expression, which is more specific and advantageous to enzyme-linked immune-sorbent assay (ELISA). However, it should be noted that the expression of a gene does not imply the production of a protein or mediator, as RNA may be degraded [30]. In addition, we evaluated the different isoforms of OPNs in the dental pulps. Based on current literatures, there is no similar study up to now.

In the present study, the two groups have a statistically significant difference in age, indicating that they were not matched (t-test) in relation to their age. It was because that the healthy samples were collected from subjects who needed orthodontic treatment. On the other hand, there is no source to suggest that OPN gene expression changes with age. Therefore, the difference in gene expression between the two groups does not seem to be due to their age difference. Chatakun et al. [31] reported in 2013 that OPN exerts a stimulatory effect on osteoblasts even in early stages. Mori et al. [32], also reported in 2010 that OPN functions as an osteoblastic marker and it is even found in stem cells that are differentiated into osteoblasts.

A higher expression of OPN in the pulpitis group and higher expression of OPN3 in healthy pulps, might be attributed to this fact that some isoforms of OPN have a more significant inflammatory roles, while in the case of OPN3 a possible protective role might be considered for it.

Rittling et al. [6] reported in 2009 that OPN has a protective role in polymicrobial endodontic infections through enhancing neutrophil function (innate immune response) but it might also enhance bone destruction associated with endodontic infections. In the present study, the relationship between OPN and the expression rate of cytokines involved in bone loss (such as RANKL and IL-1) was not evaluated, although IL-1 is one of the most important inflammatory cytokine and we considered pulpitis as an persistent inflammatory situation; therefore, it cannot be claimed that there is inconsistency between the results of the present study and the above mentioned study. Of course, if periapical lesions are studied, perhaps more relevant results can be obtained.

Kuratate et al. [14] reported in 2008 that OPN might have an inductive role in the initiation of pulp regeneration process. Shigetani et al. [33] showed that gallium-aluminum-arsenide (GaAlAs) laser irradiation of rat molars induced upregulated dentin matrix protein 1 (DMP1) and osteopontin mRNA expression in the coronal pulp, followed by the formation of reparative dentin. Tomson et al. [34] reported that hepatocyte growth factor (HGF) can increase the expression of OPN in dental pulp cells and suggested that along with other factors, it can participate in the repair of the dentine-pulp complex. Similar to the previous case, it might be pointed out that some specific isoforms of OPN, such as OPN3, might have a significant increase in response to environmental factors. It can be concluded from the overall results of the present study that there are differences in the expression of some isoforms of OPN in healthy pulp and during pulpitis. Inflammation results in an increase in the expression of OPNs. However, further studies are needed in this respect, with larger sample sizes to shed more light on the differences between the healthy and inflamed pulps. In the case of OPN2, its expression in dental pulps might be less important than the other isoforms so it might have less important role in inflammation of dental pulp.

Conclusion

The expression of OPN3 was significantly more than other OPNs in the healthy pulp and it might be concluded that OPN3 has a greater role in dental pulp and its higher expression under inflammatory conditions might be a possible mechanism to combat inflammation. OPN, exhibited a higher expression in irreversible pulpitis and it might be advisable to consider it as an inflammatory mediator rather than modulatory factor.

Acknowledgment

This study has been supported by Iranian Center for Endodontic Research, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Conflict of Interest:

‘None declared’.

References

  • 1.Kokkas A, Goulas A, Varsamidis K, Mirtsou V, Tziafas D. Irreversible but not reversible pulpitis is associated with up‐regulation of tumour necrosis factor‐alpha gene expression in human pulp. Int Endod J. 2007;40(3):198–203. doi: 10.1111/j.1365-2591.2007.01215.x. [DOI] [PubMed] [Google Scholar]
  • 2.Ghoddusi J, Zarrabi MH, Daneshvar F, Naghavi N. Efficacy of IANB and Gow-Gates Techniques in Mandibular Molars with Symptomatic Irreversible Pulpitis: A Prospective Randomized Double Blind Clinical Study. Iran Endod J. 2018;13(2):143–8. doi: 10.22037/iej.v13i2.18625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Pak JG, White SN. Pain prevalence and severity before, during, and after root canal treatment: a systematic review. J Endod. 2011;37(4):429–38. doi: 10.1016/j.joen.2010.12.016. [DOI] [PubMed] [Google Scholar]
  • 4.Asgary S, Fazlyab M, Sabbagh S, Eghbal MJ. Outcomes of different vital pulp therapy techniques on symptomatic permanent teeth: a case series. Iran Endod J. 2014;9(4):295–300. [PMC free article] [PubMed] [Google Scholar]
  • 5.Kangarlou Haghighi A, Nafarzadeh S, Shantiaee Y, Naseri M, Ahangari Z. Relation between pulpal neuropeptides and dental caries. Iran Endod J. 2010;5(3):113–6. [PMC free article] [PubMed] [Google Scholar]
  • 6.Rittling SR, Zetterberg C, Yagiz K, Skinner S, Suzuki N, Fujimura A, Sasaki H. Protective role of osteopontin in endodontic infection. Immunology. 2010;129(1):105–14. doi: 10.1111/j.1365-2567.2009.03159.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Foster B, Ao M, Salmon C, Chavez M, Kolli T, Tran A, Chu E, Kantovitz K, Yadav M, Narisawa S. Osteopontin regulates dentin and alveolar bone development and mineralization. Bone. 2018;107:196–207. doi: 10.1016/j.bone.2017.12.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Hullinger TG, Pan Q, Viswanathan HL, Somerman MJ. TGFβ and BMP-2 activation of the OPN promoter: roles of Smad-and Hox-binding elements. Experimental cell research. 2001;262(1):69–74. doi: 10.1006/excr.2000.5074. [DOI] [PubMed] [Google Scholar]
  • 9.Denhardt DT, Giachelli CM, Rittling SR. Role of osteopontin in cellular signaling and toxicant injury. Annual review of pharmacology and toxicology. 2001;41(1):723–49. doi: 10.1146/annurev.pharmtox.41.1.723. [DOI] [PubMed] [Google Scholar]
  • 10.Mckee MD, Nanci A. Osteopontin: an interfacial extracellular matrix protein in mineralized tissues. Connective tissue research. 1996;35(1-4):197–205. doi: 10.3109/03008209609029192. [DOI] [PubMed] [Google Scholar]
  • 11.Noda M, Rodan GA. Transcriptional regulation of osteopontin production in rat osteoblast-like cells by parathyroid hormone. J Cell Biol. 1989;108(2):713–8. doi: 10.1083/jcb.108.2.713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Ricardo SD, Franzoni DF, Roesener CD, Crisman JM, Diamond JR. Angiotensinogen and AT1 antisense inhibition of osteopontin translation in rat proximal tubular cells. Am J Physiol Renal Physiol. 2000;278(5):F708–F16. doi: 10.1152/ajprenal.2000.278.5.F708. [DOI] [PubMed] [Google Scholar]
  • 13.Benetti F, Briso A, Carminatti M, de Araújo Lopes J, Barbosa J, Ervolino E, Gomes‐Filho J, Cintra L. The presence of osteocalcin, osteopontin and reactive oxygen species‐positive cells in pulp tissue after dental bleaching. Int Endod J. 2019;52(5):665–75. doi: 10.1111/iej.13049. [DOI] [PubMed] [Google Scholar]
  • 14.Kuratate M, Yoshiba K, Shigetani Y, Yoshiba N, Ohshima H, Okiji T. Immunohistochemical analysis of nestin, osteopontin, and proliferating cells in the reparative process of exposed dental pulp capped with mineral trioxide aggregate. J Endod. 2008;34(8):970–4. doi: 10.1016/j.joen.2008.03.021. [DOI] [PubMed] [Google Scholar]
  • 15.Shimazu Y, Nanci A, Aoba T. Immunodetection of osteopontin at sites of resorption in the pulp of rat molars. J Histochem Cytochem. 2002;50(7):911–21. doi: 10.1177/002215540205000705. [DOI] [PubMed] [Google Scholar]
  • 16.Chang I-C, Chiang T-I, Yeh K-T, Lee H, Cheng Y-W. Increased serum osteopontin is a risk factor for osteoporosis in menopausal women. Osteoporos Int. 2010;21(8):1401–9. doi: 10.1007/s00198-009-1107-7. [DOI] [PubMed] [Google Scholar]
  • 17.Ahn H, Kim JM, Lee K, Kim H, Jeong D. Extracellular acidosis accelerates bone resorption by enhancing osteoclast survival, adhesion, and migration. Biochem Biophys Res Commun. 2012;418(1):144–8. doi: 10.1016/j.bbrc.2011.12.149. [DOI] [PubMed] [Google Scholar]
  • 18.Hao C, Cui Y, Owen S, Li W, Cheng S, Jiang WG. Human osteopontin: Potential clinical applications in cancer. Int J Mol Med. 2017;39(6):1327–37. doi: 10.3892/ijmm.2017.2964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Si J, Wang C, Zhang D, Wang B, Hou W, Zhou Y. Osteopontin in bone metabolism and bone diseases Medical science monitor. Med Sci Monit. 2020;26:e919159–1. doi: 10.12659/MSM.919159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Mark MP, Butler WT, Prince CW, Finkelman RD, Ruch J-V. Developmental expression of 44-kDa bone phosphoprotein (osteopontin) and bone γ-carboxyglutamic acid (Gla)-containing protein (osteocalcin) in calcifying tissues of rat. Differentiation. 1988;37(2):123–36. doi: 10.1111/j.1432-0436.1988.tb00804.x. [DOI] [PubMed] [Google Scholar]
  • 21.Swanson GJ, Nomura S, Hogan BL. Distribution of expression of 2AR (osteopontin) in the embryonic mouse inner ear revealed by in situ hybridisation. Hear Res. 1989;41(2-3):169–77. doi: 10.1016/0378-5955(89)90008-7. [DOI] [PubMed] [Google Scholar]
  • 22.Gimba E, Tilli T. Human osteopontin splicing isoforms: known roles, potential clinical applications and activated signaling pathways. Cancer Lett. 2013;331(1):11–7. doi: 10.1016/j.canlet.2012.12.003. [DOI] [PubMed] [Google Scholar]
  • 23.Woolson RF, Bean JA, Rojas PB. Sample size for case-control studies using Cochran's statistic. Biometrics. 1986;42(4):927–32. [PubMed] [Google Scholar]
  • 24.Sattari M, Mozayeni MA, Matloob A, Mozayeni M, Javaheri HH. Substance P and CGRP expression in dental pulps with irreversible pulpitis. Aust Endod J. 2010;36(2):59–63. doi: 10.1111/j.1747-4477.2009.00186.x. [DOI] [PubMed] [Google Scholar]
  • 25.Yin JL, Shackel NA, Zekry A, McGuinness PH, Richards C, Van Der Putten K, McCaughan GW, Eris JM, Bishop GA. Real‐time reverse transcriptase–polymerase chain reaction (RT–PCR) for measurement of cytokine and growth factor mRNA expression with fluorogenic probes or SYBR Green I. Immunol Cell Biol. 2001;79(3):213–21. doi: 10.1046/j.1440-1711.2001.01002.x. [DOI] [PubMed] [Google Scholar]
  • 26.Hsu T, Spirito SE, Pardue ML. Distribution of 18+ 28S ribosomal genes in mammalian genomes. Chromosoma. 1975;53(1):25–36. doi: 10.1007/BF00329388. [DOI] [PubMed] [Google Scholar]
  • 27.Cajazeira Aguiar M, Arana‐Chavez VE. Ultrastructural and immunocytochemical analyses of osteopontin in reactionary and reparative dentine formed after extrusion of upper rat incisors. J Anat. 2007;210(4):418–27. doi: 10.1111/j.1469-7580.2007.00708.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Kaneko T, Arayatrakoollikit U, Yamanaka Y, Ito T, Okiji T. Immunohistochemical and gene expression analysis of stem-cell-associated markers in rat dental pulp. Cell Tissue Res. 2013;351(3):425–32. doi: 10.1007/s00441-012-1539-9. [DOI] [PubMed] [Google Scholar]
  • 29.Shah D, Lynd T, Ho D, Chen J, Vines J, Jung H-D, Kim J-H, Zhang P, Wu H, Jun H-W. Pulp–dentin tissue healing response: a discussion of current biomedical approaches. J Clin Med. 2020;9(2) doi: 10.3390/jcm9020434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Greenbaum D, Colangelo C, Williams K, Gerstein M. Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol. 2003;4(9):1–8. doi: 10.1186/gb-2003-4-9-117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Chatakun P, Núñez-Toldrà R, López ED, Gil-Recio C, Martínez-Sarrà E, Hernández-Alfaro F, Ferrés-Padró E, Giner-Tarrida L, Atari M. The effect of five proteins on stem cells used for osteoblast differentiation and proliferation: a current review of the literature. Cell Mol Life Sci. 2014;71(1):113–42. doi: 10.1007/s00018-013-1326-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Mori G, Centonze M, Brunetti G, Ballini A, Oranger A, Mori C, Tetè S, Ciccolella F, Colucci S, Grano M. Osteogenic properties of human dental pulp stem cells. J Biol Regul Homeost Agents. 2010;24(2):167–75. [PubMed] [Google Scholar]
  • 33.Shigetani Y, Ohkura N, Yoshiba K, Ohshima H, Hosoya A, Yoshiba N, Okiji T. GaAlAs laser‐induced pulp mineralization involves dentin matrix protein 1 and osteopontin expression. Oral diseases. 2016;22(5):399–405. doi: 10.1111/odi.12461. [DOI] [PubMed] [Google Scholar]
  • 34.Tomson PL, Lumley PJ, Alexander MY, Smith AJ, Cooper PR. Hepatocyte growth factor is sequestered in dentine matrix and promotes regeneration-associated events in dental pulp cells. Cytokine. 2013;61(2):622–9. doi: 10.1016/j.cyto.2012.11.009. [DOI] [PubMed] [Google Scholar]

Articles from Iranian Endodontic Journal are provided here courtesy of Iranian Center for Endodontic Research

RESOURCES